These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34657538)

  • 1. Impact of cardiopulmonary bypass and surgical complexity on plasma soluble urokinase-type plasminogen activator receptor levels after cardiac surgery.
    Dardashti A; Sterner N; Fisher J; Thelaus L; Nilsson J; Linder A; Zindovic I
    Scand J Clin Lab Invest; 2021 Dec; 81(8):634-640. PubMed ID: 34657538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use.
    Gozdzik W; Adamik B; Gozdzik A; Rachwalik M; Kustrzycki W; Kübler A
    PLoS One; 2014; 9(6):e98923. PubMed ID: 24911522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
    Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery.
    Rasmussen SR; Nielsen RV; Møgelvang R; Ostrowski SR; Ravn HB
    BMC Nephrol; 2021 Apr; 22(1):120. PubMed ID: 33827466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity C-Reactive Protein on Postoperative Mortality in Patients Undergoing Elective On-Pump Cardiac Surgery.
    Rasmussen SR; Nielsen RV; Eriksson F; Dons M; Vedel AG; Buggeskov KB; Møgelvang R; Ostrowski SR; Ravn HB
    J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2415-2423. PubMed ID: 33243671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery.
    Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.
    Kokkinos A; Liaskos C; Alexiadou K; Papassotiriou I; Margeli A; Argyrakopoulou G; Perrea D; Alexandrou A; Katsilambros N; Diamantis T; Tentolouris N
    J Endocrinol Invest; 2021 Mar; 44(3):599-608. PubMed ID: 32681464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preoperative suPAR is a strong and independent risk marker for postoperative complications in patients undergoing major noncardiac surgery (SPARSE).
    Chalkias A; Laou E; Kolonia K; Ragias D; Angelopoulou Z; Mitsiouli E; Kallemose T; Smith-Hansen L; Eugen-Olsen J; Arnaoutoglou E
    Surgery; 2022 Jun; 171(6):1619-1625. PubMed ID: 34736789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble urokinase-type plasminogen activator levels are related to plasma cytokine levels but have low predictive value for mortality in trauma patients.
    Timmermans K; Vaneker M; Scheffer GJ; Maassen P; Janssen S; Kox M; Pickkers P
    J Crit Care; 2015 Jun; 30(3):476-80. PubMed ID: 25721031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Urokinase Receptor and Acute Kidney Injury.
    Hayek SS; Leaf DE; Samman Tahhan A; Raad M; Sharma S; Waikar SS; Sever S; Camacho A; Wang X; Dande RR; Ibrahim NE; Baron RM; Altintas MM; Wei C; Sheikh-Hamad D; Pan JS; Holliday MW; Januzzi JL; Weisbord SD; Quyyumi AA; Reiser J
    N Engl J Med; 2020 Jan; 382(5):416-426. PubMed ID: 31995687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
    Begum FD; Høgdall CK; Kjaer SK; Christensen L; Blaakaer J; Bock JE; Glud E; Høyer-Hansen G; Ring-Larsen H; Høgdall EV
    Anticancer Res; 2004; 24(3b):1981-5. PubMed ID: 15274388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma soluble urokinase-type plasminogen activator receptor (P-suPAR) in the diagnostics between malignant and non-malignant pancreatic lesions.
    Aronen A; Aittoniemi J; Huttunen R; Nikkola A; Nikkola J; Limnell O; Sand J; Laukkarinen J
    Pancreatology; 2023 Mar; 23(2):213-217. PubMed ID: 36596714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis.
    Slot O; Brünner N; Locht H; Oxholm P; Stephens RW
    Ann Rheum Dis; 1999 Aug; 58(8):488-92. PubMed ID: 10419867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.
    Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P
    Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble urokinase-type plasminogen activator receptor represents exercise tolerance and predicts adverse cardiac events in patients with heart failure.
    Ishikawa H; Izumiya Y; Shibata A; Ichikawa Y; Yamaguchi T; Yamaguchi Y; Kitada R; Iwata S; Ehara S; Tomita S; Hanatani A; Yoshiyama M
    Heart Vessels; 2020 May; 35(5):681-688. PubMed ID: 31741050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study.
    Backes Y; van der Sluijs KF; Tuip de Boer AM; Hofstra JJ; Vlaar AP; Determann RM; Knape P; Mackie DP; Schultz MJ
    Crit Care; 2011; 15(6):R270. PubMed ID: 22085408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia vera.
    Jensen MK; Riisbro R; de Nully Brown P; Brünner N; Hasselbalch HC
    Eur J Haematol; 2002 Jul; 69(1):43-9. PubMed ID: 12270061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.
    Alstrup M; Meyer J; Schultz M; Rasmussen LJH; Rasmussen LS; Køber L; Forberg JL; Eugen-Olsen J; Iversen K
    World J Surg; 2019 Mar; 43(3):780-790. PubMed ID: 30390135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.